Can-Fite BioPharma American Depositary Shares
CANF
12 hedge funds and large institutions have $380K invested in Can-Fite BioPharma American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 12 → 12 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
18% less capital invested
Capital invested by funds: $465K → $380K (-$84.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$12.7K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$8.49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$23.9K |
| 2 |
Morgan Stanley
New York
|
-$15.6K |
| 3 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $247K | -$15.6K | -90 | -5% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $46K | +$11.1K | +64 | +27% |
|
3
Fifth Third Bancorp
Cincinnati,
Ohio
| $23K | – | – | – |
|
|
VF
4
Virtu Financial
New York
| $22K | -$23.9K | -138 | -49% |
|
|
5
UBS Group
Zurich,
Switzerland
| $13K | +$8.49K | +49 | +129% |
|
|
TSS
6
Two Sigma Securities
New York
| $11K | +$12.7K | +73 | New |
|
7
Stifel Financial
St. Louis,
Missouri
| $9K | – | – | – |
|
8
Citigroup
New York
| $4K | – | – | – |
|
9
National Bank of Canada
Montreal,
Quebec, Canada
| $4K | – | – | – |
|
|
APA
10
American Portfolios Advisors
Holbrook,
New York
| $847 | – | – | – |
|
|
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $410 | – | – | – |
|
|
TWC
12
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $199 | – | – | – |
|
|
13
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$1K | -8 | Closed |
|
CANF Hedge Fund Activity: Q3 2022 in Review
12 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q3 2022, worth a combined $380K — down 18% from $465K a quarter earlier.
Fund positioning in CANF was balanced in Q3 2022: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $12.7K. The largest seller was Virtu Financial, cutting an estimated $23.9K.
- 12 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $380K of Can-Fite BioPharma American Depositary Shares stock for Q3 2022, down 18% quarter-over-quarter.
- 1 fund opened new Can-Fite BioPharma American Depositary Shares positions in Q3 2022 and 1 closed out, a net change of 0 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q3 2022 was Two Sigma Securities, an estimated $12.7K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q3 2022 was Virtu Financial, an estimated $23.9K sold.
Based on aggregated 13F filings for Q3 2022.